Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
IA-201
- Development stage
- Preclinical
- Lead developer
- ImmuneAGE Bio
- Modality
- Bone Marrow HSCs → Hematopoietic Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies, Peripheral Blood HSCs → Hematopoietic Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies
- Administration
- Not Explicitly Specified; Typically Hematopoietic Stem Cell Therapies Are Administered Intravenously Or Via Transplantation Procedures.
01
Overview
IA-201 is a hematopoietic stem cell therapy initially developed by Immuneage Bio. It is currently in the preclinical stage of research and development. The drug is being investigated primarily for therapeutic areas including neoplasms, immune system diseases, and cardiovascular diseases. Its active indication includes multiple myeloma. The mechanism of action involves hematopoietic stem cell therapy, which typically aims to restore or modulate the blood and immune system by transplanting or modifying stem cells.
- Other names
- IA-201IA201IA 201
Beyond the preview
Go deeper on IA-201.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IA-201.